throbber
Journal of
`Applied Bacteriology
`
`Edited by
`
`D.E. Stewart-Tull, G.I. Barrow
`
`and R.G. Board
`
`Volume 72, 1992
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 1
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 1
`
`

`

`Copyright © 1992 by The Society for Applied Bacteriology
`ALL RIGHTS RESERVED
`
`Nopart of this volume may be reproducedin any form, by
`photostat, microfilm, or any other means, without written
`permission from the Society
`
`ISSN 0021-8847
`
`Published by
`Blackwell Scientific Publications Ltd
`OXFORD LONDON EDINBURGH BOSTON
`MELBOURNE
`PARIS
`BERLIN
`VIENNA
`
`Printed in Great Britain
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 2
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 2
`
`

`

`Kinetic evaluation of claimed synergistic paraben
`combinations using a factorial design
`
`D. Gilliland, A. Li Wan Po andE. Scott
`The Drug Delivery Research Group, The School of Pharmacy, The Queen's University of Belfast, Northern Ireland
`3738/07/91: accepted 20 September 1991
`D. GILLILAND, A. LI WAN PO AND E. SCOTT. 1992. The antimicrobial effects of methyl and
`propyl parabensare investigated, with Escherichia coli as test organism, with a view to
`determining whether the parabensact synergistically. At appropriate concentrations, the
`parabenskilled E. colt cells accordingto first order kinetics and the bactericidal effects were
`quantified by thefirst order kill rate constants. Combinations of methyl or propyl parabens,
`at concentrations which slow downorinhibit bacterial growth whenusedsingly, produced
`definite kill, In this sense, the parabens are therefore synergistic since in combination they
`produce aneffect which is not observed when they are used singly. This effect is not true
`synergism as shown bytheresults of our experiments with a factorial design. Analysis of
`variance indicated no significant interaction between the two parabens.
`
`INTRODUCTION
`Combinationsof antimicrobial agents are widely used both
`for
`treating diseases and for preserving pharmaceutical
`systems. The rationale is that by using combinations, the
`activity spectrum may be broadened and the agents
`involved may act additively or synergistically. Sometimes
`one ofthe agents in a combination may by itself be inactive.
`Despite the widespread use of antimicrobial combinations,
`clinical evidence for synergy is difficult to generate even
`with in vitro systems. The best method for demonstrating
`synergism is the subject of controversy (Berenbaum 1977).
`A widely used combination preservative system for which
`there is much in-use evidence for at least an additive anti-
`microbial effect
`is
`the methyl paraben/propyl paraben
`mixture.
`In this report we describe studies designed to
`evaluate whether the two parabensact additively or syner-
`gistically. A kinetic method and a factorial experimental
`design were used.
`
`MATERIALS AND METHODS
`
`Preparation of media
`(g/l):
`The
`chemically
`defined medium contained
`Na,HPO,, 11-45; KH2PO,, 1:-4025; (NH,4)2SO,4, 1-87;
`M,SO,,
`0-187;
`D-glucose,
`0-909;
`CaCl,(2H,0),
`
`Correspondence to: Prof. A. Li Wan Po, The Drug Delivery Research
`Group, The School ofPharmacy, The Queen's University of Belfast, 97
`Lisburn Road, Belfast BT9, Northern Treland.
`
`5 x 10-7. The pH was
`1:245 x 1075; FeSO, (7H,0),
`adjusted to 6-9 with dilute HCl. All chemicals were of ana-
`lytical reagent quality.
`
`Preparation of inoculum
`Escherichia coli NCIB 8545 was maintained on Tryptone
`Soya Agar (Oxoid)slants at 4°C. A loopful of the organism
`was added to 100 mlof sterile media and grown at 37°C
`overnight in a shaking waterbath at 100 rev/min. Transfers
`of organism were made daily for 2 d. On the third transfer
`the organisms were allowed to grow to an optical density
`reading of 0-1 at 540 nm (Corning colorimeter 254). This
`provided cells in the exponential phase of growth. The
`absorbance value of 0-1 at 540 nm was found to be approx-
`imately equal to 1 x 10® cfu/ml. An inoculum of 1 x 10°
`cfu/ml was prepared by filtering the culture (100 ml),
`under aseptic conditions,
`through a 0-45 ym membrane
`filter and washing with 100 mloffresh, pre-warmed media.
`The organisms were then resuspended in 10 ml of media to
`give the final inoculum.
`
`Preparation of test solutions
`The appropriate weights of the methyl and propyl esters of
`p-hydroxybenzoic acid (Sigma) were added to 1
`1 of
`medium and placed in a sonic bath for up to 4h to aid
`solubilization. The solution was filter-sterilized and 100 ml
`of test solution dispensed into 250 ml
`flasks. Medium
`without any parabens was employed as control. Before
`inoculation, the test solutions were maintained at 37°C ina
`shaking watesbestpigptatats SPRL (IPR2019-00400)
`Exhibit 2005
`Page 3
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 3
`
`

`

`Measurementof microbial numbers
`
`After inoculation of the test solutions viable counts of
`microbial numbers were madeat regular intervals. A 1 ml
`sample was
`removed from the test solution and serial
`10-fold dilutions were made in 0-1% peptone water. One
`ml volumes of the dilutions were plated by the pour plate
`method with Isosensitest Agar (Oxoid). After incubation at
`37°C for 20 h, colonies were counted and the number of
`cfu/ml evaluated.
`
`Statistical analysis
`
`A 2? factorial design was used in our study. The low
`paraben levels corresponded to 0:12% w/v for methyl
`paraben and 0-012% w/v for propyl paraben. The high
`concentrations corresponded to 0:14% w/v for methyl
`paraben and 0-014% w/v for propyl paraben. In total 80
`kinetic runs were performed over 16 d and each day
`involved five kinetic runs. One kinetic run consisted of an
`enumeration of the number of colony-forming cells at pre-
`determined time intervals. Within-day variability was of the
`same order as between-day variability. Therefore blocking
`was not required.
`
`RESULTS
`
`Combination of methyl paraben and propyl paraben at
`0-12% w/v and 0-:014% w/v concentrations, respectively,
`produced definite kill of the E. colt cells (Fig. 1). There was
`no obvious lag phase in the kill curve and the data closely
`fitted first order kinetics. Table | lists the appropriate sta-
`tistics for the rate constants at all combinations studied.
`In order to investigate whether the two parabens in com-
`bination produced a synergistic effect we chose 0-12 and
`
`Lncfu/ml
`
` 100
`
`200
`Time (min)
`
`300
`
`400
`
`Fig. 1 A semi-logarithmic plot of the effect of 0-12% methyl
`paraben and 0-14%propyl paraben, in combination, on
`Escherichia coli. (Error bars are s.£., 1 = 5.)
`
`Table 1 The effect of concentration of methyl and propyl
`parabensalone and in combination on Escherichia coli
`
`Concentration
`(% w/v)
`
`Control
`
`0-012 propyl paraben
`0-014 propyl paraben
`0-12 methyl paraben
`+0-012 propyl paraben
`0-12 methyl paraben
`+ 0-014 propyl paraben
`0-14 methyl paraben
`+0-012 propyl paraben
`0-14 methyl paraben
`+0-014 propyl paraben
`
`First order rate
`constant (/min)
`
`0:0143
`
`0-0105
`0-0110
`
`—0-0091
`
`—0-0289
`
`—0-0385
`
`— 0-0649
`
`S.E.
`n= 20
`
`0-0003
`
`0-0003
`0-0002
`
`0-0005
`
`0-0032
`
`0-0034
`
`0-0026
`
`0:14% w/v for methyl paraben and 0-012 and 0-014% w/v
`for propyl paraben because pilot studies showed that at
`lower concentrations the combinations were often only bac-
`teriostatic and consistent kill rate constants could not be
`calculated. Combinations of higher paraben concentrations
`on the other hand killed the bacteria too quickly for the
`required sampling to be carried out satisfactorily. Conse-
`quently, the kill rate constants derived from the kill curves
`were again imprecise.
`the within-day
`Evaluation of the results showed that
`variability was of the same order as the between-day varia-
`bility. Blocking was therefore not advantageous and each
`experimental kill curve was considered to be an indepen-
`dent run.
`Analysis of variance of the rate constants showed that
`there was no synergistic effect with the two parabensat the
`concentrations used (Table 2).
`In a factorial experiment
`such as the present one,interaction is shown by a changein
`slope of the kill rate constant and concentation plot when
`the concentration of the interactant is changed. Absence of
`interaction is conversely shown by parallel lines (Cochran &
`Cox 1957) as was demonstrated in this study when the
`methyl paraben concentration was increased while main-
`taining the propyl paraben concentration at either 0-012%
`w/v (low) or 0-014% w/v (high) (Fig. 2) and, correspond-
`ingly, when the propyl paraben concentration was increased
`while maintaining the methyl paraben concentration con-
`stant.
`
`concept
`elusive
`an_
`synergism is
`Antimicrobial
`(Moellering 1979). Although the most widely accepted defi-
`nition of this term is ‘the joint action of two or moreanti-
`microbial agents to produce an effect which is greater than
`the sum of the individual effects when the drugs are used
`alone’,
`the most appropriate methodology used to prove
`synergy is still controversial. Norden (1982) showed that
`discordant conclusions are reached when results from the
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 4
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 4
`
`

`

`
`
`
`
`
`
`
`
`
`
`Sres
`Table 2 Analysis of variance for the rate
`Seq SS Adj SS Adj MS FDF PeALeetekeo
`constants from first orderkill curves of
`Methyl paraben
`methyl and propy! parabens against
`Escherichia colt
`concentration
`Propyl paraben
`0-010512
`concentration
`0-000914
`Combination
`0-010632
`76
`Error
`0-042654
`79
`Total
`ogiaie
`DF,Degrees of freedom; Seq SS, uncorrected sum of squares; Adj SS, adjusted sum of
`squares; Adj MS,adjusted mean squares; F,F-ratio.
`
`1
`
`1
`
`0-21316
`
`0-021316
`
`0-021316
`
`152-37
`
`<0-001
`
`0-010512
`0-000914
`0-010632
`
`0-010512
`0-000914
`0-000140
`
`75-14
`1:39
`
`<0-001
`0-243
`
`:
`
`a
`
`400
`
`ba
`t
`
`=Ss
`& 2e+7
`;
`2ooO
`&2
`
`9>
`
`le+7
`
`a
`
`Low
`0-12
`
`High
`0:14
`
`a
`
`5
`
`ua
`
`a
`
`Oe+0O
`
`0
`
`100
`
`200
`Time (min)
`
`Oo
`
`300
`
`0-07
`
`0-06
`
`0-05
`
`0-04
`
`0-03
`
`0-02
`
`0-01
`
`0-00
`
`
`
`
`
`Rateconstant(/min)
`
`Methyl! paraben concentration (% w/v)
`
`Fig. 2 Results of factorial design experimentto evaluate the effect
`of methyl and propyl paraben combinations on thekill rate
`constantof Escherichia coli. (Error bars are s.£., » = 20.) , Low
`propyl paraben; @, high propyl paraben
`
`checker board method are compared with those from kill
`curves that used two time points. This is not surprising
`since the checker board method uses the minimum inhibi-
`tory concentration while the kill curve method uses rate of
`kill as end-points. In our present method we have used the
`rate constants as end-points since this summary statistic
`enables us to avoid multiple comparisons of serially corre-
`lated data (Matthews et a/. 1990). With this approach we
`were not able to show any synergism in the concentration
`ranges 0:12% w/v and 0-14% w/v for methyl paraben and
`0-012% w/v and 0-014% w/v for propyl paraben.
`It
`is interesting to note however that 0:12% w/v and
`0:14% w/v methyl paraben when used alone produced a
`bacteriostatic effect (Fig. 3). Propyl paraben at 0-012% w/v
`
`Fig. 3 The survival of exponential phase Escherichia coli cells in
`chemically defined media in the presence of 0:12%w/v and
`0-14%w/v methyl paraben.(Error barsare s.£., 2 = 5.) D,
`0-12% methyl paraben; @, 0:14% methyl paraben
`
`and 0-014% w/v on the other hand allowed bacterial
`growth to continue when used singly (Fig. 4). Yet every
`combination within those concentration ranges produced
`bacterial kill (Fig. 5). The results therefore clearly show
`that in this sense the combination is synergistic, that is the
`combination produces an effect (observable kill) which is
`not seen when the agents are used singly.
`To explain why there is this apparent sudden change
`from a bacteriostatic to a bactericidal effect for the paraben
`combination it is worth noting that with most drug entities,
`the dose-response relationship is not linear but sigmoidal
`(Goldstein et
`af.
`1974). Therefore apparently abrupt
`changes in potency are often observed. The danger of mis-
`taking this change for synergism has been highlighted by
`Berenbaum (1977).
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 5
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 5
`
`

`

`7e+8
`
`6e+8
`
`5e+8
`
`4e+8
`
`se+8
`
`2e+8
`
`le+8
`
`
`
`
`
`Viablecount(cfu/ml)
`
`
`
`Lnviablecount
`
`a
`
`o
`
`100
`
`
`Ge +02eeEeeeee
`0
`100
`200
`300
`400
`Time (min)
`
`
`
`300
`200
`Time (min)
`
`400
`
`500
`
`Fig. 4 The growth of exponential phase Escherichia coh cells in
`chemically defined media in the presence of 0-012% propyl
`paraben andin the presence of 0-014% propyl paraben. (Error
`bars are S.E., 2 = 5.) 1), 0-012%propyl paraben; @, 0:014%
`propyl paraben
`
`REFERENCES
`
`BERENBAUM, M.C. (1977) Synergy, additivism and antagonism
`in immunosuppression. A critical review. Clinical and Experi-
`mental Immunology 28, 1-18.
`Cocuran, W.G. & Cox, G.M. (1957) Factorial experiments.
`In Experimental Designs, pp. 148-181. New York: Wiley.
`GoLpsTEIN, A., ARoNow, L. & KALMAN, S.M. (1974)
`Molecular mechanisms of drug action. In Principles of Drug
`Action, 2nd edn. Ch. 1, pp. 1-128. New York: Wiley Interna-
`tional.
`
`Fig. 5 The survival of exponential phase Escherichia colt cells in
`chemically defined media in the presence of combinations of
`methyl and propyl parabensat high (H) and low (L)
`concentrations. (Error bars are s.£.,2 = 5.) 1], L methyl + L
`propyl; @, H methyl + L propyl; Mf, L methyl + H propyl; O,
`H methyl + H propyl
`
`MatTHews, J.N.S., ALTMAN, D.G., CAMPBELL, M.J.
`& Royston, P.
`(1990) Analysis of serial measurements in
`medical research. British Medical Journal 300, 230-235.
`MOELLERING, R.C.
`(1979) Antimicrobial
`synergism—an
`elusive concept. Journal of Infectious Diseases 140, 639-641.
`Norben, C.W. (1982) Problems in determination of antibiotic
`synergism in vitro. Reviews ofInfectious Diseases 4, 276-281.
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 6
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2005
`Page 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket